Search results
Results from the WOW.Com Content Network
AMAG Pharmaceuticals (AMAG) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
AMAG's main product, Ferumoxytol was estimated by the company to generate revenue of $71.5 million in 2013. [5] In August 2013, the company received a new U.S. patent for Ferumoxytol, expiring in 2020. [6] In June 2015, the company acquired Cord Blood Registry for $700 million. [7] In 2014, AMAG acquired Lumara Health, formerly KV ...
For premium support please call: 800-290-4726 more ways to reach us
"The Daily Show was based on an emerging 24 hour news cycle, that’s everything it was, that’s what inspired The Daily Show. Now you look at news and it’s changed. It’s no longer predicated around 24 hour news. There are so many different choices. Half of it is online now. Now you’ve got the Gawkers, the BuzzFeeds. The way people are ...
For premium support please call: 800-290-4726 more ways to reach us
8 AMAG: New hot rolling mill in Ranshofen puts AMAG in the top league. (No longer available online.) In: www.AMAG.at. AMAG, November 25, 2014, archived from the original on April 9, 2018; retrieved April 9, 2018. 9 AMAG: AMAG opens Europe's most modern aluminum cold rolling mill. In: www.AMAG.at. AMAG, June 23, 2017; retrieved April 9, 2018.